Feb 25 (Reuters) - ABIONYX PHARMA SA ABNX.PA :
* ANNUAL RESULTS 2020
* NET RESULT WAS A LOSS OF EUR 1,886 K AT 31 DECEMBER 2020
COMPARED WITH A PROFIT OF EUR 1,849 K AT 31 DECEMBER 2019
* CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 9,154 K AT 31
DECEMBER
2020, COMPARED WITH EUR 8,331 K AT 31 DECEMBER 2019
* FY: NO REVENUE
* OPERATING PROFIT FELL FROM A LOSS OF EUR 2,525 K AT 31
DECEMBER
2019 TO A LOSS OF EUR 2,968 K AT 31 DECEMBER 2020
* FY NET LOSS EUR 1.9 MILLION VERSUS PROFIT OF EUR 1.8
MILLION
YEAR AGO
Source text for Eikon: ID:nBw5pHvY2a
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))